Edesa Biotech, Inc.
NASDAQ:EDSA
1.59 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Edesa Biotech, Inc. |
Symbool | EDSA |
Munteenheid | USD |
Prijs | 1.59 |
Beurswaarde | 5,513,233 |
Dividendpercentage | 0% |
52-weken bereik | 1.55 - 5.99 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Pardeep Nijhawan FRCPC, M.D. |
Website | https://www.edesabiotech.com |
An error occurred while fetching data.
Over Edesa Biotech, Inc.
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in covid-19
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)